Literature DB >> 26726734

Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on α-Synuclein Aggregation and Toxicity.

Yuka E Lewis1, Tharindumala Abeywardana1, Yu Hsuan Lin1, Ana Galesic1, Matthew R Pratt1.   

Abstract

The reversible modification of protein by the small protein ubiquitin and other ubiquitin-like modifiers plays important roles in virtually every key biological process in eukaryotic cells. The establishment of a range of chemical methods for the preparation of ubiquitinated proteins has enabled the site-specific interrogation of the consequences of these modifications. However, many of these techniques require significant levels of synthetic expertise, somewhat limiting their widespread application by the biological community. To overcome this issue, the creation of structural analogues of the ubiquitin-protein linkage that can be readily prepared with commercially available reagents and buffers is an important goal. Here we present the development of conditions for the facile synthesis of bis-thio-acetone (BTA) linkages of ubiquitinated proteins in high yields. Additionally, we apply this technique to the preparation of the aggregation prone protein α-synuclein bearing either ubiquitin or the small ubiquitin-like modifier (SUMO). With these proteins, we demonstrate that the BTA linkage recapitulates the previously published effects of either of these proteins on α-synuclein, suggesting that it is a good structural mimic. Notably, the BTA linkage is chemically and enzymatically stable, enabling us to study the consequences of site-specific ubiquitination and SUMOylation on the toxicity of α-synuclein in cell culture, which revealed modification and site-specific differences.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26726734      PMCID: PMC6300141          DOI: 10.1021/acschembio.5b01042

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  59 in total

1.  Nonhydrolyzable diubiquitin analogues are inhibitors of ubiquitin conjugation and deconjugation.

Authors:  L Yin; B Krantz; N S Russell; S Deshpande; K D Wilkinson
Journal:  Biochemistry       Date:  2000-08-15       Impact factor: 3.162

2.  Auxiliary-mediated site-specific peptide ubiquitylation.

Authors:  Champak Chatterjee; Robert K McGinty; Jean-Philippe Pellois; Tom W Muir
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

3.  Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.

Authors:  Masato Hasegawa; Hideo Fujiwara; Takashi Nonaka; Koichi Wakabayashi; Hitoshi Takahashi; Virginia M-Y Lee; John Q Trojanowski; David Mann; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2002-10-10       Impact factor: 5.157

4.  Intravesicular localization and exocytosis of alpha-synuclein and its aggregates.

Authors:  He-Jin Lee; Smita Patel; Seung-Jae Lee
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

5.  Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult.

Authors:  M Lee; D Hyun; B Halliwell; P Jenner
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

6.  Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity.

Authors:  S J Tabrizi; M Orth; J M Wilkinson; J W Taanman; T T Warner; J M Cooper; A H Schapira
Journal:  Hum Mol Genet       Date:  2000-11-01       Impact factor: 6.150

7.  Ubiquitination of alpha-synuclein.

Authors:  Takashi Nonaka; Takeshi Iwatsubo; Masato Hasegawa
Journal:  Biochemistry       Date:  2005-01-11       Impact factor: 3.162

8.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

9.  Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies.

Authors:  Deepak M Sampathu; Benoit I Giasson; Aaron C Pawlyk; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

10.  Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein.

Authors:  Véronique Dorval; Paul E Fraser
Journal:  J Biol Chem       Date:  2006-02-07       Impact factor: 5.157

View more
  8 in total

Review 1.  Chemoenzymatic Semisynthesis of Proteins.

Authors:  Robert E Thompson; Tom W Muir
Journal:  Chem Rev       Date:  2019-11-27       Impact factor: 60.622

2.  Ubiquitination Can Change the Structure of the α-Synuclein Amyloid Fiber in a Site Selective Fashion.

Authors:  Stuart P Moon; Aaron T Balana; Ana Galesic; Ananya Rakshit; Matthew R Pratt
Journal:  J Org Chem       Date:  2019-12-19       Impact factor: 4.354

Review 3.  Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools.

Authors:  Isabelle Landrieu; Elian Dupré; Davy Sinnaeve; Léa El Hajjar; Caroline Smet-Nocca
Journal:  Front Chem       Date:  2022-05-12       Impact factor: 5.545

4.  Chemical Protein Ubiquitylation with Preservation of the Native Cysteine Residues.

Authors:  Kun Yang; Guorui Li; Ping Gong; Weijun Gui; Libo Yuan; Zhihao Zhuang
Journal:  Chembiochem       Date:  2016-04-26       Impact factor: 3.164

Review 5.  Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.

Authors:  Luis M A Oliveira; Thomas Gasser; Robert Edwards; Markus Zweckstetter; Ronald Melki; Leonidas Stefanis; Hilal A Lashuel; David Sulzer; Kostas Vekrellis; Glenda M Halliday; Julianna J Tomlinson; Michael Schlossmacher; Poul Henning Jensen; Julia Schulze-Hentrich; Olaf Riess; Warren D Hirst; Omar El-Agnaf; Brit Mollenhauer; Peter Lansbury; Tiago F Outeiro
Journal:  NPJ Parkinsons Dis       Date:  2021-07-26

6.  Genetically Directed Production of Recombinant, Isosteric and Nonhydrolysable Ubiquitin Conjugates.

Authors:  Mathew Stanley; Satpal Virdee
Journal:  Chembiochem       Date:  2016-06-27       Impact factor: 3.164

Review 7.  Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications.

Authors:  Rosie Bell; Michele Vendruscolo
Journal:  Front Neurol       Date:  2021-07-15       Impact factor: 4.003

Review 8.  Consequences of post-translational modifications on amyloid proteins as revealed by protein semisynthesis.

Authors:  Stuart P Moon; Aaron T Balana; Matthew R Pratt
Journal:  Curr Opin Chem Biol       Date:  2021-06-25       Impact factor: 8.972

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.